Merck KGaA (ETR:MRK)
112.15
-2.80 (-2.44%)
Oct 30, 2025, 5:00 PM CET
Merck KGaA Revenue
Merck KGaA had revenue of 5.26B EUR in the quarter ending June 30, 2025, a decrease of -1.81%. This brings the company's revenue in the last twelve months to 21.22B, up 1.67% year-over-year. In the year 2024, Merck KGaA had annual revenue of 21.16B with 0.78% growth.
Revenue (ttm)
21.22B
Revenue Growth
+1.67%
P/S Ratio
2.36
Revenue / Employee
335.96K
Employees
59,020
Market Cap
49.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
| Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
| Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
| Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
| Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 46.17B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.28B |
| Fresenius Medical Care AG | 19.52B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.68B |
| Fielmann Group AG | 2.40B |
| Carl Zeiss Meditec AG | 2.18B |
Merck KGaA News
- 6 days ago - Merck KGaA: An AI-Resistant Pharma Play - Seeking Alpha
- 7 days ago - Merck KGaA (MKKGY) Analyst/Investor Day - Slideshow - Seeking Alpha
- 9 days ago - SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology - Wallstreet:Online
- 13 days ago - Merck KGaA Reaches Deal With U.S. To Cut Prices On IVF Drugs - Nasdaq
- 13 days ago - Merck KGaA (MKGAF) Offers Major IVF Discount in New US Deal - GuruFocus
- 13 days ago - Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs. - MarketWatch
- 13 days ago - Trump announces efforts to expand access to IVF drugs - CNBC
- 14 days ago - Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets - WSJ